Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy

Parkinsonism and Related Disorders

Volumn 13, Issue 8, 2007, Pages 516-519

  McKeon, Andrew ^a   Josephs, Keith A ^a   Klos, Kevin J ^a   Hecksel, Kathleen ^a   Bower, James H ^a   Michael Bostwick, J ^a   Eric Ahlskog, J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Compulsions; Dopamine agonists

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERPHAGIA; HYPERSEXUALITY; MALE; MONOTHERAPY; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; SHY DRAGER SYNDROME; TREATMENT DURATION;

AGED; COMPULSIVE BEHAVIOR; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; RETROSPECTIVE STUDIES;

EID: 36048948590     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.04.004     Document Type: Article

References (14)

1. Dodd M.L., Klos K.J., Bower J.H., Geda Y.E., Josephs K.A., and Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62 9 (2005) 1377-1381
2. Pontone G., Williams J.R., Bassett S.S., and Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67 7 (2006) 1258-1261
3. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67 7 (2006) 1254-1257
4. Klos K.J., Bower J.H., Josephs K.A., Matsumoto J.Y., and Ahlskog J.E. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 11 6 (2005) 381-386
5. Nirenberg M.J., and Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 21 4 (2006) 524-529
6. Evans A.H., Katzenschlager R., Paviour D., O'Sullivan J.D., Appel S., Lawrence A.D., et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19 4 (2004) 397-405
7. Rylander G. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75 3 (1972) 203-212
8. Fernandez H.H., and Friedman J.H. Punding on l-dopa. Mov Disord 14 5 (1999) 836-838
9. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Mov Disord 19 4 (2004) 367-370
10. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., and Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 6289 (1990) 146-151
11. Perachon S., Schwartz J.C., and Sokoloff P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. Eur J Pharmacol 366 2-3 (1999) 293-300
12. Shapiro M.A., Chang Y.L., Munson S.K., Okun M.S., and Fernandez H.H. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases. Parkinsonism Relat Disord 12 6 (2006) 392-395
13. Miwa H., Morita S., Nakanishi I., and Kondo T. Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease. Parkinsonism Relat Disord 10 3 (2004) 177-180
14. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63 7 (2006) 969-973